BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17828507)

  • 1. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
    Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
    Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
    Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
    He XF; Wen DG; Hou JQ; He J; Cen JN
    Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
    Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
    Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of Survivin in transitional cell carcinoma of urinary bladder and its clinical significance].
    Xiao ZJ; Zheng S; Chen W; Zhang HF; Li CL; Gao YN
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1977-9. PubMed ID: 15730809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
    Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer.
    Wu Y; Wang G; Wei J; Wen X
    Indian J Med Sci; 2005 Jun; 59(6):235-42. PubMed ID: 15988093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of Livin in the progression of bladder cancer.
    Zhu Z; Wang Y; Ding X; Zeng F; Xu K
    J Huazhong Univ Sci Technolog Med Sci; 2008 Feb; 28(1):90-2. PubMed ID: 18278467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
    Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
    East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells.
    Tyagi AK; Agarwal C; Singh RP; Shroyer KR; Glode LM; Agarwal R
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1178-84. PubMed ID: 14651997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
    Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
    Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y; Mowla SJ; Ziaee SA
    Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The apoptosis inhibitor survivin in transitional cell carcinoma of the urinary bladder].
    Vol'pina OM; Zavalishina LE; Volkova TD; Akhidova EV; Koroev DO; Andreeva IuIu; Petrov AN; Frank GA
    Arkh Patol; 2011; 73(2):8-10. PubMed ID: 21695980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence.
    Schultz IJ; Kiemeney LA; Willems JL; Swinkels DW; Witjes JA; de Kok JB
    Clin Chem; 2006 Jul; 52(7):1440-2. PubMed ID: 16798976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expression of survivin mRNA in urine exfoliated cells of patients with bladder transitional cell carcinoma detected by real-time PCR].
    Sun J; Hou JQ; He J; He XF; Wen DG
    Ai Zheng; 2009 Oct; 28(10):1100-2. PubMed ID: 19799821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders.
    Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA
    Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and significance of survivin mRNA in urinary bladder carcinomas.
    Wang H; Xi X; Kong X; Huang G; Ge G
    J Cancer Res Clin Oncol; 2004 Aug; 130(8):487-90. PubMed ID: 15138808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinico-pathological significance of protein expression of PAK1 in bladder transitional cell carcinoma].
    Zhang YH; Xie D; Luo JH; Chen W; Chen LW; Xu QC; Liu GY; Ma HB; Lin WQ
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2710-3. PubMed ID: 18167251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder.
    Ku JH; Kwak C; Lee HS; Park HK; Lee E; Lee SE
    J Urol; 2004 Feb; 171(2 Pt 1):631-5. PubMed ID: 14713775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma.
    Lehner R; Lucia MS; Jarboe EA; Orlicky D; Shroyer AL; McGregor JA; Shroyer KR
    Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):134-8. PubMed ID: 12051631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.